🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Saxagliptin Anhydrous

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Saxagliptin Anhydrous, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bdb
2 shared targets
vildagliptin
3 shared targets
diprotin
2 shared targets
linagliptin
3 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
Sitagliptin
3 shared targets · score 72.1
Loading evidence profile...

This evidence profile for Saxagliptin Anhydrous is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.